Bosentan use in interstitial lung disease (open label). Long-term open-label study in patients with interstitial lung disease associated with systemic sclerosis who completed the protocol AC-052-330/BUILD 2. Bosentan use in interstitial lung disease (open label). Long-term open-label study in patients with ...
Bosentan use in interstitial lung disease (open label). Long-term open-label study in patients with interstitial lung disease associated with systemic sclerosis who completed the protocol AC-052-330/BUILD 2. Bosentan use in interstitial lung disease (open label). Long-term open-label study in patients with ...
Interstitial lung disease associated with systemic sclerosis
Trade Name: TRACLEER*125MG 56CPR RIV. Product Name: NA Product Code: NA INN or Proposed INN: Bosentan
Uncontrolled extension trial to protocol AC-052-406 to evaluate the long term effect of bosentan therapy in patient with pulmonary arterial hypertension related to connective tissue disease (TRUST-extension) Uncontrolled extension trial to protocol AC-052-406 to evaluate the long term effect of bosentan the ...
Uncontrolled extension trial to protocol AC-052-406 to evaluate the long term effect of bosentan therapy in patient with pulmonary arterial hypertension related to connective tissue disease (TRUST-extension) Uncontrolled extension trial to protocol AC-052-406 to evaluate the long term effect of bosentan the ...
No modification of the label due to the fact that is an open label extension of a phase IV trial. MedDRA version: 6.1;Level: PT;Classification code 10037406 No modification of the label due to the fact that is an open label extension of a phase IV trial. Me ...
Trade Name: TRACLEER*125MG 56CPR RIV. INN or Proposed INN: Bosentan